Clinical experience combined with therapeutic drug monitoring of lacosamide.

Torleiv SvendsenEylert BrodtkorbArton BaftiuMorten I LossiusKarl O NakkenSvein I JohannessenCecilie Johannessen Landmark

Published in: Acta neurologica Scandinavica (2020)

Lacosamide was generally well tolerated in patients with drug-resistant epilepsy, where one third had ID, and in these patients the retention rate was higher. The combination of clinical and TDM data could possibly facilitate LCM therapy in these vulnerable patients.

Keyphrases

drug resistant
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
acinetobacter baumannii
patient reported outcomes
machine learning
big data
electronic health record
cell therapy
cystic fibrosis
smoking cessation
chemotherapy induced